There is now a third vaccine that prevents COVID-19 infections. It isn't quite as effective as the other two vaccines but it has advantages that may...
Record hospitalizations and a surging death toll failed to keep Americans from traveling a day before the Thanksgiving holiday, raising fears that the unchecked spread under...
Two biotechs said they got turned away by the FDA on Wednesday, in part due to pandemic-related travel restrictions. North Carolina-based Liquidia Technologies was handed a...
Maryland-based Altimmune Inc. has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to commence a Phase 1 clinical study of its...
Daily U.S. deaths from Covid-19 surpassed 2,000 for the first time since May and with hospitals across the country already full, portending a surge in mortalities...
Moderna has inked a deal to supply European Union countries with up to 160 million doses of its COVID-19 vaccine candidate. The supply deal comes after...
U.S. officials plan to release 6.4 million Covid-19 vaccine doses nationwide in an initial distribution after the first one is cleared by regulators for emergency use.
Genentech’s influenza treatment Xofluza (baloxavir marboxil) was granted approval by the U.S. Food and Drug Administration for use in people 12 years and older, making it...
Agilent Technologies shares were down 3.6% in pre-market trading on Tuesday despite the company reporting better-than-anticipated results for the fourth quarter of FY20 (ended Oct. 31)....
People of color & those with lower incomes or education levels less likely to say they’ll seek vaccination against a disease that’s high risk for older...
The FDA has approved a new use for Xofluza (baloxavir marboxil) from Roche’s Genentech unit, to prevent people The post FDA approves Roche’s Xofluza to prevent...
Novartis announced on Tuesday that it will initiate a share buyback plan of up to $2.5 billion, which will start immediately and is expected to last...
Generally, companies in the healthcare sector show resilience amid challenging macro conditions. However, certain healthcare stocks have been under pressure during the pandemic due to supply...
Unfortunately, Covid-19 is still on the rampage across the globe. However, the good news is that the newest data coming from late stage studies indicates a...
The U.S. government will start distributing Regeneron Pharmaceuticals Inc.’s newly authorized Covid-19 antibody combination on Nov. 24, beginning with more than 30,000 treatment courses, a health...
Demand for vaccine storage freezers, three companies told GEN, extends beyond traditional customers such as biopharmas and academic labs to include healthcare providers and pharmacies, many...
CNBC Transcript: Regeneron Chairman and CEO Dr. Leonard Schleifer speaks With CNBC’s Meg Tirrell on “Squawk Box” today on the distribution of Covid-19 antibody cocktail. Q3...
First on CNBC: CNBC Transcript: Dr. Ruud Dobber, President of AstraZeneca US and EVP of BioPharmaceuticals, speaks with CNBC’s “Squawk Box” today explaining their positive Covid...
US dollar remains under pressure The US dollar rose on Friday as investors continued to take risk off the board into the weekend. Those gains have...
CNBC Exclusive: CNBC Transcript: Oncolmmune Founder and CEO Dr. Yang Liu speaks with CNBC’s “Squawk Box” today, discussing Oncolmmune being acquired by Merck. Q3 2020 hedge...
Merck & Co has entered into a definitive agreement to snap up all of the outstanding shares of drugmaker OncoImmune for an upfront payment of $425...
Precision BioSciences shares surged 10.7% on Nov. 20 as the biotechnology company along with Eli Lilly (LLY) announced a research collaboration and exclusive license agreement to...
Asia higher on vaccine hopes, stimulus talks Although Wall Street saw continued profit-taking push equities to a lower close on Friday, the US index futures have...
AstraZeneca said that its coronavirus vaccine candidate, which it is developing together with Oxford University, has shown an average efficiency of 70% and met the primary...
U.S. healthcare workers and others recommended for the nation’s first Covid-19 inoculations could start getting shots within a day or two of regulatory consent in December,...
Shares of Avrobio plunged 17.6% on Friday after the clinical-stage gene therapy company kicked off a secondary offering of 5 million common shares. The offering is...
The U.S. Food and Drug Administration issued emergency use authorization for Regeneron Pharmaceuticals Inc.’s Covid-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump...
More Than 2/3rds Of Americans Oppose Mandatory COVID-19 Vaccinations Tyler Durden Sun, 11/22/2020 - 13:40 Ever since it burst out of Wuhan, China roughly one year...
Regeneron announced that its REGN-COV2 investigational antibody cocktail therapy for the treatment of COVID-19, has been granted Emergency Use Authorization (EUA) by the US Food and...
The US Food and Drug Administration (FDA) will review Pfizer Inc. and BioNTech’s request for emergency use authoriziation (EUA) of their COVID-19 vaccine candidate on Dec....